Compare PLETHICO PHARMA with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA CADILA HEALTHCARE PLETHICO PHARMA/
CADILA HEALTHCARE
 
P/E (TTM) x -1.1 14.5 - View Chart
P/BV x 0.0 2.8 0.6% View Chart
Dividend Yield % 0.0 1.4 -  

Financials

 PLETHICO PHARMA   CADILA HEALTHCARE
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
CADILA HEALTHCARE
Mar-18
PLETHICO PHARMA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs395558 70.8%   
Low Rs31362 8.7%   
Sales per share (Unadj.) Rs604.4116.3 519.7%  
Earnings per share (Unadj.) Rs32.517.9 181.8%  
Cash flow per share (Unadj.) Rs51.323.1 221.9%  
Dividends per share (Unadj.) Rs03.50 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs473.685.4 554.4%  
Shares outstanding (eoy) m34.081,023.74 3.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.44.0 8.9%   
Avg P/E ratio x6.625.7 25.5%  
P/CF ratio (eoy) x4.219.9 20.9%  
Price / Book Value ratio x0.55.4 8.4%  
Dividend payout %019.6 0.0%   
Avg Mkt Cap Rs m7,262470,664 1.5%   
No. of employees `000NA11.8 0.0%   
Total wages/salary Rs m1,59618,545 8.6%   
Avg. sales/employee Rs ThNM10,072.7-  
Avg. wages/employee Rs ThNM1,569.1-  
Avg. net profit/employee Rs ThNM1,547.7-  
INCOME DATA
Net Sales Rs m20,598119,049 17.3%  
Other income Rs m3861,132 34.1%   
Total revenues Rs m20,984120,181 17.5%   
Gross profit Rs m2,81828,475 9.9%  
Depreciation Rs m6425,388 11.9%   
Interest Rs m1,593911 174.9%   
Profit before tax Rs m96923,308 4.2%   
Minority Interest Rs m0628 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1385,644 -2.5%   
Profit after tax Rs m1,10718,292 6.1%  
Gross profit margin %13.723.9 57.2%  
Effective tax rate %-14.324.2 -59.0%   
Net profit margin %5.415.4 35.0%  
BALANCE SHEET DATA
Current assets Rs m18,87782,005 23.0%   
Current liabilities Rs m11,89660,720 19.6%   
Net working cap to sales %33.917.9 189.5%  
Current ratio x1.61.4 117.5%  
Inventory Days Days3673 49.1%  
Debtors Days Days19898 201.2%  
Net fixed assets Rs m9,86183,703 11.8%   
Share capital Rs m3411,024 33.3%   
"Free" reserves Rs m12,33186,421 14.3%   
Net worth Rs m16,13987,445 18.5%   
Long term debt Rs m4,70625,551 18.4%   
Total assets Rs m33,146180,653 18.3%  
Interest coverage x1.626.6 6.0%   
Debt to equity ratio x0.30.3 99.8%  
Sales to assets ratio x0.60.7 94.3%   
Return on assets %8.110.6 76.6%  
Return on equity %6.920.9 32.8%  
Return on capital %12.322.0 55.9%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Exports (fob) Rs m4,402NA-   
Imports (cif) Rs m3,136NA-   
Fx inflow Rs m4,40242,683 10.3%   
Fx outflow Rs m3,18411,242 28.3%   
Net fx Rs m1,21931,441 3.9%   
CASH FLOW
From Operations Rs m2,4379,193 26.5%  
From Investments Rs m-6,265-9,737 64.3%  
From Financial Activity Rs m2,490515 483.5%  
Net Cashflow Rs m-1,337-29 4,610.9%  

Share Holding

Indian Promoters % 82.7 74.8 110.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 8.3 51.8%  
FIIs % 5.5 5.9 93.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 11.0 68.2%  
Shareholders   10,665 44,069 24.2%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   WOCKHARDT  J.B.CHEMICALS  PROCTER & GAMBLE HEALTH  BIOCON   FULFORD INDIA  

Compare PLETHICO PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - PANACEA BIOTECH COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS